| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |